The Role of TPA in Stroke Prevention

In the outpatient setting, we do have zedia or azetamide, which is less helpful for low density lipoprotein specifically. There's also the infusion agents such as PCSK9 inhibitors. These are monoclonal antibodies typically given through injection. Those are expensive and can be challenging to get approval for but effective at lowering LDL in somebody for whom statins alone are inadequate,. or statins are contraindicated or not tolerated.